Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy.
Van de Voorde M, Duchemin C, Heinke R, Lambert L, Chevallay E, Schneider T, Van Stenis M, Cocolios TE, Cardinaels T, Ponsard B, Ooms M, Stora T, Burgoyne AR.
Van de Voorde M, et al. Among authors: ponsard b.
Front Med (Lausanne). 2021 Jul 19;8:675221. doi: 10.3389/fmed.2021.675221. eCollection 2021.
Front Med (Lausanne). 2021.
PMID: 34350194
Free PMC article.